Jeffrey Langsam

Chief Clinical Officer, Starling Oncology, Inc.

Companies

Starling Oncology, Inc.Chief Clinical Officer May 23, 2025 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Starling Oncology, Inc. STLN127,650 shares²$873.1K at $6.84Mar 27, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 27, 2026Granted 70,270 shares of Starling Oncology, Inc.²
May 21, 2025Granted 57,380 shares of Starling Oncology, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARStarling Oncology, Inc., Chief Clinical Officer
2
SEC EDGARStarling Oncology, Inc. shares after the filing of Mar 27, 2026
3
SEC EDGARForm 4 filed May 23, 2025